Clinical Pediatric Pneumonia Score in Critically Ill Children

Withdrawn before enrolling

Conditions studied: Community Acquired Pneumonia

In brief

The purpose of the study is to create a clinical pneumonia tool that can be used to predict the cause of community-acquired pneumonia, which is a lung infection that began outside of the hospital in critically ill children therefore limiting unnecessary antibiotic use. The investigators will enroll critically ill children admitted with acute respiratory failure and suspected pneumonia. Each patient will receive a clinical pneumonia score blinded from culture and respiratory viral panel results. All care after samples obtained will be at the discretion of the PICU team. The investigators believe that our clinical pneumonia scale with procalcitonin will accurately designate viral from bacterial etiologies.

Key facts

Study ID

NCT02139384

Run by

Loma Linda University

People needed

0

Starts

2012-08-01

Expected to finish

2013-01-01

Last updated by the study team

2017-04-25

Who can join

Age: 0 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All intubated pediatric patients
• Age 1 day to 21 years
• Admitted to the LLUCH PICU with suspected pneumonia for the next 6 months
• Have received antibiotics for less than 12 hours
• Have been intubated for less than 24 hours
• Patients must be English or Spanish speaking for consent purposes.

You may not qualify if…

• Patients who have received antibiotics for greater than 12 hours
• Patients who have been intubated for greater than 24 hours
• Patients who are unable to tolerate non-bronchoscopic bronchoalveolar lavage

Where it is running

• Loma Linda University Children's Hospital — Loma Linda, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.